Table 4.
Variable | Level | aOR | 95% CI | p-value | |
---|---|---|---|---|---|
Insurance (baseline) | Yes (ref: No) | 2.30 | 1.12 | 4.72 | 0.024 |
Number male partners | 5-24 (ref: 0-4) | 1.05 | 0.55 | 1.99 | 0.885 |
>=25 (ref: 0-4) | 1.02 | 0.49 | 2.14 | 0.955 | |
Prior miscarriage | Yes (ref: No) | 1.25 | 0.73 | 2.14 | 0.412 |
Alcohol use (previous visit) | Drinkers (ref: abstainers) | 2.96 | 1.71 | 5.12 | <0.001 |
Marijuana use (previous visit) | Yes (ref: No) | 1.58 | 0.75 | 3.32 | 0.226 |
Cigarette smoking (previous visit) | Yes (ref: No) | 2.20 | 1.26 | 3.85 | 0.006 |
Pregnancy year | 1998-2001 (ref: 1994-1997) | 1.02 | 0.45 | 2.34 | 0.961 |
2002-2005 (ref: 1994-1997) | 0.80 | 0.37 | 1.75 | 0.576 | |
>=2006 (ref: 1994-1997) | 1.30 | 0.56 | 3.05 | 0.540 | |
HIV viral load <4 log10 copies/mL (previous visit) | Yes (ref: No) | 0.45 | 0.24 | 0.84 | 0.013 |
ART regimen | cART containing II, NRTI, NNRTI (ref: No cART) | 0.69 | 0.34 | 1.40 | 0.302 |
cART containing PI (ref: No cART) | 0.40 | 0.21 | 0.79 | 0.008 |
Mixed models with random intercept and unstructured covariance matrix
aOR: adjusted odds ratio; CI: confidence interval; ref: reference; WIHS: Women's Interagency HIV Study; cART: combination highly active antiretroviral therapy; NNRTI: non-nucleoside reverse transcriptase inhibitors; NRTI: nucleoside reverse transcriptase inhibitors; PI: protease inhibitor
p-values are two-tailed